Leopard syndrome overview: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(36 intermediate revisions by 2 users not shown)
Line 4: Line 4:


==Overview==
==Overview==
Leopard syndrome is a rare [[autosomal dominant]],<ref>{{cite journal |author=Coppin BD, Temple IK |title=Multiple lentigines syndrome (LEOPARD syndrome or progressive cardiomyopathic lentiginosis) |journal=J. Med. Genet. |volume=34 |issue=7 |pages=582–6 |year=1997 |pmid=9222968 |doi=}}</ref> multisystem disease caused by a [[mutation]] in the [[protein tyrosine phosphatase]], non-receptor type 11 gene ([[PTPN11]])The disease is a complex of features, mostly involving the skin, skeletal and cardiovascular systems, they may or may not be present in all patients.  The nature of how the mutation causes each of the condition's symptoms is not well known, however research is ongoing.  Related to [[Noonan syndrome]], Leopard syndrome is caused by a different [[missense mutation]] of the same gene.  Leopard syndrome may also be called multiple lentigines syndrome, cardiomyopathic lentiginosis, Gorlin's syndrome II, Capute-Rimoin-Konigsmark-Esterly-Richardson syndrome, or Moynahan syndrome.  [[Noonan syndrome]] is fairly common (1:1000 to 1:2500 live births), and [[Neurofibromatosis type I|neurofibromatosis 1]] (which was once thought to be related to Leopard syndrome) is also common (1:3500), but however no epidemiologic data exists for Leopard syndrome.<ref>{{cite journal |author=Tullu MS, Muranjan MN, Kantharia VC, ''et al'' |title=Neurofibromatosis-Noonan syndrome or LEOPARD Syndrome? A clinical dilemma |journal=J Postgrad Med |volume=46 |issue=2 |pages=98–100 |year=2000 |pmid=11013475 |url=http://www.jpgmonline.com/article.asp?issn=0022-3859;year=2000;volume=46;issue=2;spage=98;epage=100}}</ref>
LEOPARD syndrome is a rare [[autosomal dominant]],<ref>{{cite journal |author=Coppin BD, Temple IK |title=Multiple lentigines syndrome (LEOPARD syndrome or progressive cardiomyopathic lentiginosis) |journal=J. Med. Genet. |volume=34 |issue=7 |pages=582–6 |year=1997 |pmid=9222968 |doi=}}</ref> caused by a [[mutation]] in the [[PTPN11|protein tyrosine phosphatase non-receptor type 11 gene]].  Many systems can be involved, mostly involving the skin, skeletal and cardiovascular systems, but in other cases they are absent.  The word LEOPARD is an acronym for the major features of this disorder, including multiple '''L'''entigines, '''E'''KG abnormalities, '''O'''cular hypertelorism, '''P'''ulmonic stenosis, '''A'''bnormal genitalia, '''R'''etardation of growth, and sensorineural '''D'''eafness


==Historical Perspective==
==Historical Perspective==
It was first described by Zeisler and Becker with multiple [[lentigo|lentigines]], [[hypertelorism]], [[pectus carinatum]] (protruding breastbone) and [[prognathism]] (protrusion of lower jaw) in 1936.<ref name="Zeisler1936">{{cite journal|last1=Zeisler|first1=Erwin P.|title=GENERALIZED LENTIGO<subtitle>ITS RELATION TO SYSTEMIC NONELEVATED NEVI</subtitle>|journal=Archives of Dermatology|volume=33|issue=1|year=1936|pages=109|issn=0003-987X|doi=10.1001/archderm.1936.01470070112010}}</ref>
It was first described by Zeisler and Becker with multiple [[lentigo|lentigines]], [[hypertelorism]], [[pectus carinatum]] (protruding breastbone) and [[prognathism]] (protrusion of lower jaw) in 1936.<ref name="Zeisler1936">{{cite journal|last1=Zeisler|first1=Erwin P.|title=GENERALIZED LENTIGO<subtitle>ITS RELATION TO SYSTEMIC NONELEVATED NEVI</subtitle>|journal=Archives of Dermatology|volume=33|issue=1|year=1936|pages=109|issn=0003-987X|doi=10.1001/archderm.1936.01470070112010}}</ref>
In 1962, cardiac abnormalities and short stature were first associated with the condition.<ref name="Zeisler1936">{{cite journal|last1=Zeisler|first1=Erwin P.|title=GENERALIZED LENTIGO<subtitle>ITS RELATION TO SYSTEMIC NONELEVATED NEVI</subtitle>|journal=Archives of Dermatology|volume=33|issue=1|year=1936|pages=109|issn=0003-987X|doi=10.1001/archderm.1936.01470070112010}}</ref>
In 1962, cardiac abnormalities and short stature were first associated with the condition.<ref name="Zeisler1936">{{cite journal|last1=Zeisler|first1=Erwin P.|title=GENERALIZED LENTIGO<subtitle>ITS RELATION TO SYSTEMIC NONELEVATED NEVI</subtitle>|journal=Archives of Dermatology|volume=33|issue=1|year=1936|pages=109|issn=0003-987X|doi=10.1001/archderm.1936.01470070112010}}</ref>
In 1966, three familial cases were added.<ref>{{cite journal |author=Walther RJ, Polansky BJ, Grotis IA |title=Electrocardiographic abnormalities in a family with generalized lentigo |journal=N. Engl. J. Med. |volume=275 |issue=22 |pages=1220–5 |year=1966 |pmid=5921856 |doi=}}</ref>  In 1968 another case of mother to two separate children, with different paternity of the two children, was added.<ref>{{cite journal |author=Matthews NL |title=Lentigo and electrocardiographic changes |journal=N. Engl. J. Med. |volume=278 |issue=14 |pages=780–1 |year=1968 |pmid=5638719 |doi=}}</ref>
It was believed as late as 2002<ref>[http://www.nlm.nih.gov/cgi/mesh/2006/MB_cgi?mode=&term=LEOPARD+Syndrome&field=entry National Library of Medicine MeSH: C05.660.207.525]</ref> that Leopard syndrome was related to [[neurofibromatosis type I]] (von Recklinghausen syndrome).


==Pathophysiology==
==Pathophysiology==
In the two predominant mutations of Leopard syndrome, the mutations cause a loss of [[catalytic activity]] of the SHP2 protein(the gene product of the ''[[PTPN11]]'' gene), which is a previously unrecognized behavior for this class of mutations.<ref>{{cite journal |author=Tartaglia M, Martinelli S, Stella L, ''et al'' |title=Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease |journal=Am. J. Hum. Genet. |volume=78 |issue=2 |pages=279–90 |year=2006 |pmid=16358218 |doi=10.1086/499925}}</ref> This interferes with growth factor and related signalling. While further research confirms this mechanism,<ref>{{cite journal |author=Hanna N, Montagner A, Lee WH, ''et al'' |title=Reduced phosphatase activity of SHP-2 in LEOPARD syndrome: consequences for PI3K binding on Gab1 |journal=FEBS Lett. |volume=580 |issue=10 |pages=2477–82 |year=2006 |pmid=16638574 |doi=10.1016/j.febslet.2006.03.088}}</ref><ref>{{cite journal |author=Kontaridis MI, Swanson KD, David FS, Barford D, Neel BG |title=PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects |journal=J. Biol. Chem. |volume=281 |issue=10 |pages=6785–92 |year=2006 |pmid=16377799 |doi=10.1074/jbc.M513068200|url=http://www.jbc.org/cgi/content/full/281/10/6785}}</ref> additional research is needed to determine how this relates to all of the observed effects of Leopard syndrome.
LEOPARD syndrome is most commonly caused by [[missense mutation]]s in the [[PTPN11]] gene. It has also been associated with other gene mutations such as [[c-Raf|RAF1]] and [[BRAF]].


==Causes==
==Epidemiology and Demographics==
Molecular studies have shown that Leopard syndrome is caused by different missense mutations in [[PTPN11]], a gene encoding the protein tyrosine phosphatase SHP-2 located at chromosome 12q22-qter.<ref name="Digilio-2006">{{Cite journal | last1 = Digilio | first1 = MC. | last2 = Sarkozy | first2 = A. | last3 = de Zorzi | first3 = A. | last4 = Pacileo | first4 = G. | last5 = Limongelli | first5 = G. | last6 = Mingarelli | first6 = R. | last7 = Calabrò | first7 = R. | last8 = Marino | first8 = B. | last9 = Dallapiccola | first9 = B. | title = LEOPARD syndrome: clinical diagnosis in the first year of life. | journal = Am J Med Genet A | volume = 140 | issue = 7 | pages = 740-6 | month = Apr | year = 2006 | doi = 10.1002/ajmg.a.31156 | PMID = 16523510 }}</ref>
Leopaed syndrome is a rare condition, but the exact birth prevalence is unknown.  Approximately 200 patients have been reported.<ref name="pmid1258892">{{cite journal| author=Voron DA, Hatfield HH, Kalkhoff RK| title=Multiple lentigines syndrome. Case report and review of the literature. | journal=Am J Med | year= 1976 | volume= 60 | issue= 3 | pages= 447-56 | pmid=1258892 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1258892  }} </ref> However, LEOPARD syndrome is likely underdiagnosed or misdiagnosed as many of its features are mild and the correct diagnosis might be missed in the absence of [[lentiginosis]].
the mutations cause a loss of [[catalytic activity]] of the SHP2 protein (the gene product of the PTPN11 gene), which is a previously unrecognized behavior for this class of mutations.<ref name="Tartaglia-2006">{{Cite journal  | last1 = Tartaglia | first1 = M. | last2 = Martinelli | first2 = S. | last3 = Stella | first3 = L. | last4 = Bocchinfuso | first4 = G. | last5 = Flex | first5 = E. | last6 = Cordeddu | first6 = V. | last7 = Zampino | first7 = G. | last8 = Burgt | first8 = Iv. | last9 = Palleschi | first9 = A. | title = Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease. | journal = Am J Hum Genet | volume = 78 | issue = 2 | pages = 279-90 | month = Feb | year = 2006 | doi = 10.1086/499925 | PMID = 16358218 }}</ref> This interferes with growth factor and related signalling.


==Epidemiology and Demographics==
==Natural History, Complications and Prognosis==
Leopaed syndrome is a rare condition, but the exact birth prevalence is unknownNot less than 200 patients have been reported and two reviews published.<ref name="Voron-1976">{{Cite journal | last1 = Voron | first1 = DA. | last2 = Hatfield | first2 = HH. | last3 = Kalkhoff | first3 = RK. | title = Multiple lentigines syndrome. Case report and review of the literature. | journal = Am J Med | volume = 60 | issue = 3 | pages = 447-56 | month = Mar | year = 1976 | doi = | PMID = 1258892 }}</ref>
In general, males are more affected than females.  LEOPARD syndrome is not a life threatening diagnosis, cardiomyopathy and other pathologic findings involving the cardiovascular system may be a cause of death in those whose cardiac deformities are profound.
However, Leopard syndrome is likely underdiagnosed or misdiagnosed as many of its features are mild and the correct diagnosis might be missed in the absence of [[lentiginosis]].
 
==History and Symptoms==
LEOPARD syndrome affects many areas in the body.  The characteristic feature associated with the condition is brown skin spots called [[lentigines]]Patients are showing a wide spectrum of features include multiple lentigines, facial dysmorphisms, cardiac anomalies, electrocardiographic (EKG) conduction abnormalities, [[Failure to thrive|retardation of growth]], abnormal genitalia and [[Sensorineural hearing loss|sensorineural deafness]].<ref name="pmid5771505">{{cite journal| author=Gorlin RJ, Anderson RC, Blaw M| title=Multiple lentigenes syndrome. | journal=Am J Dis Child | year= 1969 | volume= 117 | issue= 6 | pages= 652-62 | pmid=5771505 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=5771505  }} </ref>
 
===Laboratory Findings===
Hormonal abnormalities may be revealed in some patients with endocrine system involvement.  laboratory studies should include molecular analysis of the [[PTPN11]] and [[c-Raf|RAF1]] genes.<ref>{{cite journal |author=Digilio MC, Sarkozy A, de Zorzi A, ''et al'' |title=LEOPARD syndrome: clinical diagnosis in the first year of life |journal=Am. J. Med. Genet. A |volume=140 |issue=7 |pages=740–6 |year=2006 |pmid=16523510 |doi=10.1002/ajmg.a.31156}}</ref>
 
===Imaging Studies===
Different imaging studies like [[X-rays]], [[CT scanning]], and [[Echocardiography]] have been used to detect abnormalities of LEOPARD syndrome.
 
==Medical Therapy==
Medical management depend on the symptoms present.  Drug therapy for cardiac abnormalities,endocrine, and dermatological issues is recommended.
 
==Surgical Therapy==
Different procedures may be necessary in cases with severe outflow tract obstruction<ref name="pmid17697839">{{cite journal| author=Limongelli G, Pacileo G, Marino B, Digilio MC, Sarkozy A, Elliott P et al.| title=Prevalence and clinical significance of cardiovascular abnormalities in patients with the LEOPARD syndrome. | journal=Am J Cardiol | year= 2007 | volume= 100 | issue= 4 | pages= 736-41 | pmid=17697839 | doi=10.1016/j.amjcard.2007.03.093 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17697839  }} </ref>, patients with [[cryptorchidism]], genitourinary, or severe skeletal deformity.
 
==Primary Prevention==
Genetic counseling should be offered before deciding to have children, careful examination of all family members as the syndrome usually present with incomplete form.
 
==Secondary Prevention==
Once a decision to have children is made and the couple conceives, the fetus is monitored during the pregnancy for cardiac evaluation.  If a gross cardiac malformation is found, parents receive counseling on continuing with the pregnancy.


==References==
==References==

Latest revision as of 19:47, 16 September 2013

Leopard syndrome Microchapters

Home

Overview

Historical Perspective

Pathophysiology

Differentiating Leopard syndrome from other Diseases

Epidemiology and Demographics

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Laboratory Findings

Imaging Findings

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Leopard syndrome overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Leopard syndrome overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Leopard syndrome overview

CDC on Leopard syndrome overview

Leopard syndrome overview in the news

Blogs on Leopard syndrome overview

Directions to Hospitals Treating Leopard syndrome

Risk calculators and risk factors for Leopard syndrome overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]

Overview

LEOPARD syndrome is a rare autosomal dominant,[1] caused by a mutation in the protein tyrosine phosphatase non-receptor type 11 gene. Many systems can be involved, mostly involving the skin, skeletal and cardiovascular systems, but in other cases they are absent. The word LEOPARD is an acronym for the major features of this disorder, including multiple Lentigines, EKG abnormalities, Ocular hypertelorism, Pulmonic stenosis, Abnormal genitalia, Retardation of growth, and sensorineural Deafness

Historical Perspective

It was first described by Zeisler and Becker with multiple lentigines, hypertelorism, pectus carinatum (protruding breastbone) and prognathism (protrusion of lower jaw) in 1936.[2] In 1962, cardiac abnormalities and short stature were first associated with the condition.[2]

Pathophysiology

LEOPARD syndrome is most commonly caused by missense mutations in the PTPN11 gene. It has also been associated with other gene mutations such as RAF1 and BRAF.

Epidemiology and Demographics

Leopaed syndrome is a rare condition, but the exact birth prevalence is unknown. Approximately 200 patients have been reported.[3] However, LEOPARD syndrome is likely underdiagnosed or misdiagnosed as many of its features are mild and the correct diagnosis might be missed in the absence of lentiginosis.

Natural History, Complications and Prognosis

In general, males are more affected than females. LEOPARD syndrome is not a life threatening diagnosis, cardiomyopathy and other pathologic findings involving the cardiovascular system may be a cause of death in those whose cardiac deformities are profound.

History and Symptoms

LEOPARD syndrome affects many areas in the body. The characteristic feature associated with the condition is brown skin spots called lentigines. Patients are showing a wide spectrum of features include multiple lentigines, facial dysmorphisms, cardiac anomalies, electrocardiographic (EKG) conduction abnormalities, retardation of growth, abnormal genitalia and sensorineural deafness.[4]

Laboratory Findings

Hormonal abnormalities may be revealed in some patients with endocrine system involvement. laboratory studies should include molecular analysis of the PTPN11 and RAF1 genes.[5]

Imaging Studies

Different imaging studies like X-rays, CT scanning, and Echocardiography have been used to detect abnormalities of LEOPARD syndrome.

Medical Therapy

Medical management depend on the symptoms present. Drug therapy for cardiac abnormalities,endocrine, and dermatological issues is recommended.

Surgical Therapy

Different procedures may be necessary in cases with severe outflow tract obstruction[6], patients with cryptorchidism, genitourinary, or severe skeletal deformity.

Primary Prevention

Genetic counseling should be offered before deciding to have children, careful examination of all family members as the syndrome usually present with incomplete form.

Secondary Prevention

Once a decision to have children is made and the couple conceives, the fetus is monitored during the pregnancy for cardiac evaluation. If a gross cardiac malformation is found, parents receive counseling on continuing with the pregnancy.

References

  1. Coppin BD, Temple IK (1997). "Multiple lentigines syndrome (LEOPARD syndrome or progressive cardiomyopathic lentiginosis)". J. Med. Genet. 34 (7): 582–6. PMID 9222968.
  2. 2.0 2.1 Zeisler, Erwin P. (1936). "GENERALIZED LENTIGO<subtitle>ITS RELATION TO SYSTEMIC NONELEVATED NEVI</subtitle>". Archives of Dermatology. 33 (1): 109. doi:10.1001/archderm.1936.01470070112010. ISSN 0003-987X.
  3. Voron DA, Hatfield HH, Kalkhoff RK (1976). "Multiple lentigines syndrome. Case report and review of the literature". Am J Med. 60 (3): 447–56. PMID 1258892.
  4. Gorlin RJ, Anderson RC, Blaw M (1969). "Multiple lentigenes syndrome". Am J Dis Child. 117 (6): 652–62. PMID 5771505.
  5. Digilio MC, Sarkozy A, de Zorzi A; et al. (2006). "LEOPARD syndrome: clinical diagnosis in the first year of life". Am. J. Med. Genet. A. 140 (7): 740–6. doi:10.1002/ajmg.a.31156. PMID 16523510.
  6. Limongelli G, Pacileo G, Marino B, Digilio MC, Sarkozy A, Elliott P; et al. (2007). "Prevalence and clinical significance of cardiovascular abnormalities in patients with the LEOPARD syndrome". Am J Cardiol. 100 (4): 736–41. doi:10.1016/j.amjcard.2007.03.093. PMID 17697839.

Template:WH Template:WS